Logins
Logins Use the links below for logging in to Advarra products and service portals. Advarra’s electronic institutional review board (IRB)
Universal
Contact Us
Contact Us To obtain employment, salary, or social service verification please visit www.vaultverify.com and enter company code 88710.
Site-Sponsor Consortium
Site-Sponsor Consortium The Power of Collaboration in Clinical Research The Site-Sponsor Consortium is a small, invitation-only collaborative designed to bring
HIPAA Compliance Statement
HIPAA Compliance Statement This HIPAA compliance statement describes Advarra’s policies, procedures, controls, and measures to ensure current and ongoing compliance.
About Advarra
About Advarra Advarra is #1 in trusted clinical research review services and #1 in trusted site and sponsor technology. Our
2024 Site-Sponsor-CRO Collaboration Survey Report
The Site-Sponsor-CRO Collaboration Survey Report highlights challenges in collaboration, offering actionable insights from 200+ professionals to improve trials.
News
Advarra Newsroom FEATURED NEWS Kodiak Sciences Selects Advarra for IRB Services and Technology Partner for Ophthalmology Clinical Trials In the
Oncology Clinical Research
SOLUTIONS FOR Oncology Clinical Research As a cancer research leader, you face unique challenges requiring specialized support and expertise. Whether
Leadership Team
LeadershipTeam Gadi Saarony, MBA Chief Executive Officer Scott Uebele, MBA Chief Operating Officer Dwight Van Inwegen Chief Financial Officer Marco
Privacy Policy
Overview Advarra, Inc., doing business as Advarra®, and any of our subsidiaries or affiliates (collectively, “Advarra”), provide this policy so
Making Good Clinical Practice More Understandable
This eBook dives into GCP’s role in the clinical research ecosystem and how it protects participant rights, safety, and confidentiality.
Clinical Research Trends in 2023: What’s Driving Change and What Challenges Remain?
The clinical research industry has undergone significant transformation in recent years, especially in the wake of the COVID-19 pandemic.